TriangleHEALTH PROFESSIONAL · SOURCE READING
Palliative chemotherapy and other systemic therapy
Source: Cervical Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: May 13, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Chemotherapy can be used for palliation. Drugs used for palliative chemotherapy are shown in Table 6.
Source links and citations
| Drug Name | Response Rate |
|---|---|
| Cisplatin [8] | 15%–25% |
| Ifosfamide [9,10] | 15%–30% |
| Paclitaxel [11] | 17% |
| Irinotecan [12] | 21% in patients previously treated with chemotherapy |
| Bevacizumab [13] | 11%; 24% survived progression free for at least 6 months, as seen in GOG-0227C (NCT00025233) |
| Ifosfamide/cisplatin [14,15] | 31% |
| Paclitaxel/cisplatin [16] | 46% |
| Cisplatin/gemcitabine [17] | 41% |
| Cisplatin/topotecan [18] | 27% |
| Cisplatin/vinorelbine [19] | 30% |
Continue within this section
Studies cited in this source section
Source citation is not a determination that a study applies to you.
Publication references
Read the original reference and check its publication notices.
- PubMed 10561341 · Original source
- PubMed 10620443 · Original source
- PubMed 15310778 · Original source
- PubMed 15911865 · Original source
- PubMed 19139430 · Original source
- PubMed 2464699 · Original source
- PubMed 2910782 · Original source
- PubMed 3802384 · Original source
- PubMed 8456884 · Original source
- PubMed 8622025 · Original source
- PubMed 8996138 · Original source
- PubMed 9053486 · Original source
Preserved source evidence · Not medical advice